Ob/Gyn Medical News about breast cancer; MRI

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Role of MRI in breast cancer management
Cleveland Clinic Journal of Medicine, 09/03/09

Enriquez L et al. – Magnetic resonance imaging (MRI) is highly sensitive for cancer staging, problem–solving, posttreatment surveillance, and other indications. It can detect primary breast cancers and additional foci of cancer that are occult to standard imaging. Continued improvements in technology and studies to assess outcomes will help to better define MRI’s role in breast cancer.

Whether rates of death and local recurrence are reduced when additional breast tumors found by MRI are treated remains to be seen.
MRI contrast enhancement occurs in many cancers, but it may occur for benign reasons; thus, the finding of contrast enhancement does not establish the diagnosis of breast cancer.
The National Comprehensive Cancer Network currently recommends screening with both mammography and MRI starting at age 20 to 25 for women at high risk of hereditary breast cancer and ovarian cancer.
A breast MRI evaluation costs about 10 times more than screening mammography and may not be covered by health insurance, but coverage for this indication appears to be improving gradually.

<< Previous
Letrozole combined with norethisterone acetate compared with...

Next >>
Guidelines on CMV congenital infection